Anika Therapeutics's total assets for Q3 2025 were $189.44M, an increase of 0.94% from the previous quarter. ANIK total liabilities were $42.63M for the fiscal quarter, a 6.55% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.